Titre : Produits chimiques et pharmaceutiques

Produits chimiques et pharmaceutiques : Questions médicales fréquentes

Termes MeSH sélectionnés :

Pilot Projects
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Produits chimiques et pharmaceutiques : Questions médicales les plus fréquentes", "headline": "Produits chimiques et pharmaceutiques : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Produits chimiques et pharmaceutiques : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-06-19", "dateModified": "2025-03-16", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Produits chimiques et pharmaceutiques" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "about": { "@type": "MedicalCondition", "name": "Produits chimiques et pharmaceutiques", "alternateName": "Chemicals and Drugs", "code": { "@type": "MedicalCode", "code": "MD", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Nicolas Simon", "url": "https://questionsmedicales.fr/author/Nicolas%20Simon", "affiliation": { "@type": "Organization", "name": "Pharmacy, Geneva University Hospitals and School of Pharmaceutical Sciences, University of Geneva, University of Lausanne, Geneva, Switzerland." } }, { "@type": "Person", "name": "Pascal Odou", "url": "https://questionsmedicales.fr/author/Pascal%20Odou", "affiliation": { "@type": "Organization", "name": "Univ. Lille, CHU Lille, EA 7365-GRITA-Groupe de Recherche sur les Formes Injectables et les Technologies Associées, Lille, France." } }, { "@type": "Person", "name": "José L Medina-Franco", "url": "https://questionsmedicales.fr/author/Jos%C3%A9%20L%20Medina-Franco", "affiliation": { "@type": "Organization", "name": "DIFACQUIM Research Group, Department of Pharmacy, School of Chemistry, Universidad Nacional Autónoma de México, Mexico City, Mexico." } }, { "@type": "Person", "name": "Hongbin Yang", "url": "https://questionsmedicales.fr/author/Hongbin%20Yang", "affiliation": { "@type": "Organization", "name": "Yusuf Hamied Department of Chemistry, University of Cambridge, Lensfield Road, CB2 1EW, Cambridge, United Kingdom." } }, { "@type": "Person", "name": "Chiara Borsari", "url": "https://questionsmedicales.fr/author/Chiara%20Borsari", "affiliation": { "@type": "Organization", "name": "Department of Biomedicine, University of Basel, Mattenstrasse 28, 4058 Basel, Switzerland." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Changes in the hydro-climatic regime of the Hunza Basin in the Upper Indus under CMIP6 climate change projections.", "datePublished": "2022-12-12", "url": "https://questionsmedicales.fr/article/36509796", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41598-022-25673-6" } }, { "@type": "ScholarlyArticle", "name": "Projecting Long-Term Care Costs for Home and Community-Based Services in China from 2005 to 2050.", "datePublished": "2022-12-08", "url": "https://questionsmedicales.fr/article/36502859", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jamda.2022.11.005" } }, { "@type": "ScholarlyArticle", "name": "Trends in cardiovascular care in the National Health System in Spain. Data from the RECALCAR project 2011-2020.", "datePublished": "2022-12-06", "url": "https://questionsmedicales.fr/article/36493955", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.rec.2022.09.017" } }, { "@type": "ScholarlyArticle", "name": "Predicting treatment outcomes of the Empowerment group intervention for refugees with affective disorders: Findings from the MEHIRA project.", "datePublished": "2022-11-23", "url": "https://questionsmedicales.fr/article/36427652", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jad.2022.11.050" } }, { "@type": "ScholarlyArticle", "name": "pISA-tree - a data management framework for life science research projects using a standardised directory tree.", "datePublished": "2022-11-10", "url": "https://questionsmedicales.fr/article/36357404", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41597-022-01805-5" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Produits chimiques et pharmaceutiques", "item": "https://questionsmedicales.fr/mesh/MD" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Produits chimiques et pharmaceutiques - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Produits chimiques et pharmaceutiques", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-15", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Produits chimiques et pharmaceutiques", "description": "Comment les médicaments sont-ils testés avant leur approbation ?\nQu'est-ce qu'un test de toxicité ?\nQuels sont les biomarqueurs utilisés en pharmacologie ?\nComment évaluer l'efficacité d'un médicament ?\nQu'est-ce qu'une interaction médicamenteuse ?", "url": "https://questionsmedicales.fr/mesh/MD?mesh_terms=Pilot+Projects&page=997#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Produits chimiques et pharmaceutiques", "description": "Quels symptômes peuvent indiquer une intoxication médicamenteuse ?\nComment reconnaître une réaction allergique à un médicament ?\nQuels sont les effets secondaires courants des antibiotiques ?\nQuels symptômes indiquent un surdosage ?\nComment identifier une dépendance à un médicament ?", "url": "https://questionsmedicales.fr/mesh/MD?mesh_terms=Pilot+Projects&page=997#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Produits chimiques et pharmaceutiques", "description": "Comment prévenir les effets secondaires des médicaments ?\nQuels vaccins sont considérés comme des produits pharmaceutiques ?\nComment réduire le risque d'interactions médicamenteuses ?\nQuelles sont les mesures préventives pour éviter les infections ?\nComment la recherche contribue-t-elle à la prévention des maladies ?", "url": "https://questionsmedicales.fr/mesh/MD?mesh_terms=Pilot+Projects&page=997#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Produits chimiques et pharmaceutiques", "description": "Quels sont les traitements pour une surdose médicamenteuse ?\nComment les médicaments sont-ils administrés ?\nQu'est-ce que la thérapie génique ?\nQuels sont les traitements pour les infections bactériennes ?\nComment les médicaments anticancéreux fonctionnent-ils ?", "url": "https://questionsmedicales.fr/mesh/MD?mesh_terms=Pilot+Projects&page=997#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Produits chimiques et pharmaceutiques", "description": "Quelles complications peuvent survenir avec les antibiotiques ?\nQuels sont les risques d'une surdose médicamenteuse ?\nComment les médicaments peuvent-ils affecter la grossesse ?\nQuelles complications peuvent résulter d'un traitement prolongé ?\nQuels sont les effets à long terme des médicaments psychotropes ?", "url": "https://questionsmedicales.fr/mesh/MD?mesh_terms=Pilot+Projects&page=997#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Produits chimiques et pharmaceutiques", "description": "Quels facteurs augmentent le risque d'effets secondaires ?\nComment l'usage de médicaments peut-il varier selon l'âge ?\nQuels comportements augmentent le risque de dépendance ?\nComment les antécédents familiaux influencent-ils le risque médicamenteux ?\nQuels facteurs environnementaux influencent l'usage des médicaments ?", "url": "https://questionsmedicales.fr/mesh/MD?mesh_terms=Pilot+Projects&page=997#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment les médicaments sont-ils testés avant leur approbation ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Les médicaments subissent des essais cliniques en plusieurs phases pour évaluer leur sécurité et efficacité." } }, { "@type": "Question", "name": "Qu'est-ce qu'un test de toxicité ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Un test de toxicité évalue les effets nocifs d'une substance chimique sur des organismes vivants." } }, { "@type": "Question", "name": "Quels sont les biomarqueurs utilisés en pharmacologie ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les biomarqueurs sont des indicateurs biologiques mesurables de l'effet d'un médicament sur l'organisme." } }, { "@type": "Question", "name": "Comment évaluer l'efficacité d'un médicament ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "L'efficacité est évaluée par des études cliniques comparant le médicament à un placebo ou à un traitement standard." } }, { "@type": "Question", "name": "Qu'est-ce qu'une interaction médicamenteuse ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Une interaction médicamenteuse se produit lorsque deux médicaments affectent mutuellement leur efficacité ou sécurité." } }, { "@type": "Question", "name": "Quels symptômes peuvent indiquer une intoxication médicamenteuse ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent nausées, vomissements, confusion, et troubles respiratoires." } }, { "@type": "Question", "name": "Comment reconnaître une réaction allergique à un médicament ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Les réactions allergiques peuvent se manifester par des éruptions cutanées, démangeaisons ou œdème." } }, { "@type": "Question", "name": "Quels sont les effets secondaires courants des antibiotiques ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Les effets secondaires incluent diarrhée, nausées, et réactions allergiques." } }, { "@type": "Question", "name": "Quels symptômes indiquent un surdosage ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes de surdosage varient selon le médicament, mais peuvent inclure confusion et troubles cardiaques." } }, { "@type": "Question", "name": "Comment identifier une dépendance à un médicament ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Les signes incluent un besoin compulsif de la substance, des symptômes de sevrage et des comportements de recherche." } }, { "@type": "Question", "name": "Comment prévenir les effets secondaires des médicaments ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La prévention inclut une prescription appropriée, une surveillance et l'éducation des patients." } }, { "@type": "Question", "name": "Quels vaccins sont considérés comme des produits pharmaceutiques ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Les vaccins contre la grippe, l'hépatite et le tétanos sont des exemples de produits pharmaceutiques préventifs." } }, { "@type": "Question", "name": "Comment réduire le risque d'interactions médicamenteuses ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Il est essentiel de consulter un professionnel de santé avant de prendre plusieurs médicaments." } }, { "@type": "Question", "name": "Quelles sont les mesures préventives pour éviter les infections ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Les mesures incluent la vaccination, l'hygiène et l'utilisation prudente des antibiotiques." } }, { "@type": "Question", "name": "Comment la recherche contribue-t-elle à la prévention des maladies ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "La recherche développe de nouveaux médicaments et stratégies pour prévenir et traiter les maladies." } }, { "@type": "Question", "name": "Quels sont les traitements pour une surdose médicamenteuse ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement peut inclure l'administration d'antidotes, le lavage gastrique ou des soins de soutien." } }, { "@type": "Question", "name": "Comment les médicaments sont-ils administrés ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Les médicaments peuvent être administrés par voie orale, intraveineuse, topique ou inhalée." } }, { "@type": "Question", "name": "Qu'est-ce que la thérapie génique ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "La thérapie génique utilise des médicaments pour traiter des maladies en modifiant les gènes défectueux." } }, { "@type": "Question", "name": "Quels sont les traitements pour les infections bactériennes ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Les infections bactériennes sont généralement traitées avec des antibiotiques spécifiques." } }, { "@type": "Question", "name": "Comment les médicaments anticancéreux fonctionnent-ils ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Ils ciblent les cellules cancéreuses pour inhiber leur croissance ou provoquer leur mort." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec les antibiotiques ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des infections fongiques, des réactions allergiques et des résistances." } }, { "@type": "Question", "name": "Quels sont les risques d'une surdose médicamenteuse ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Les risques incluent des lésions organiques, des troubles neurologiques et la mort." } }, { "@type": "Question", "name": "Comment les médicaments peuvent-ils affecter la grossesse ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Certains médicaments peuvent causer des malformations congénitales ou des complications pendant la grossesse." } }, { "@type": "Question", "name": "Quelles complications peuvent résulter d'un traitement prolongé ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des effets secondaires chroniques et des dépendances." } }, { "@type": "Question", "name": "Quels sont les effets à long terme des médicaments psychotropes ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Les effets à long terme peuvent inclure des troubles cognitifs, des dépendances et des effets sur l'humeur." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque d'effets secondaires ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "L'âge, le poids, les maladies préexistantes et les interactions médicamenteuses augmentent le risque." } }, { "@type": "Question", "name": "Comment l'usage de médicaments peut-il varier selon l'âge ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Les personnes âgées peuvent être plus sensibles aux effets des médicaments en raison de changements physiologiques." } }, { "@type": "Question", "name": "Quels comportements augmentent le risque de dépendance ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "L'usage récréatif, l'automédication et l'absence de suivi médical augmentent le risque de dépendance." } }, { "@type": "Question", "name": "Comment les antécédents familiaux influencent-ils le risque médicamenteux ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Les antécédents familiaux de maladies peuvent prédisposer à des réactions indésirables aux médicaments." } }, { "@type": "Question", "name": "Quels facteurs environnementaux influencent l'usage des médicaments ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "L'accès aux soins, la culture et l'éducation influencent l'usage et la prescription des médicaments." } } ] } ] }

Sources (10000 au total)

Projecting Long-Term Care Costs for Home and Community-Based Services in China from 2005 to 2050.

The aim of this study was to estimate and project the trend in long-term care (LTC) costs for home and community-based services as a percentage of gross domestic product in China between 2005 and 2050... Longitudinal.... We used 61,249 observations from 37,702 adults age ≥65 years from waves 2005, 2008, 2011, 2014, and 2018 of the Chinese Longitudinal Healthy Longevity Surveys.... LTC costs for home and community-based services consisted of the monetary value of time spent on LTC and the direct LTC cost. We used the age-sex-residence-specific weights provided by the Chinese Lon... The percentage of older adults with disabilities was projected to increase from 6.1% in 2005 to 7.5% in 2020 and 9.6% in 2050. The total LTC cost for home and community-based services were projected t... Policymakers in China should take urgent actions to delay the onset of disabilities among older adults, which would curb the increasing LTC costs and maintain the sustainability of the LTC policies....

Trends in cardiovascular care in the National Health System in Spain. Data from the RECALCAR project 2011-2020.

The RECALCAR project (Resources and Quality in Cardiology), an initiative of the Spanish Society of Cardiology, aims to standardize information to generate evidence on cardiovascular health outcomes. ... The study was based on the 2 annual data sources of the RECALCAR project: a survey on resources and activity of cardiology units and/or services (2011-2020) and the minimum data set of the National He... The survey included 70% of cardiology units and/or services in Spain. The number of hospital beds and length of stay decreased, while there was a notable increase in the number of cardiac imaging stud... The information provided by the RECALCAR project shows a favorable trend in the last decade in resources, activity and results of certain cardiovascular processes and constitutes an essential source f...

Predicting treatment outcomes of the Empowerment group intervention for refugees with affective disorders: Findings from the MEHIRA project.

Research on outcome predictors in the field of transcultural treatment for refugees and asylum seekers (RAS) is scarce. We aimed to evaluate predictors of outcome of a group intervention (Empowerment)... A predictor analysis was performed at level three of the MEHIRA project, where 149 refugees with moderate depressive symptoms were treated either with Empowerment or Treatment-as-usual (TAU). Outcome ... Intention-to-treat (ITT) analyses revealed significant linear relationships between change in PHQ-9 and baseline depression severity (β = -0.35, t = -3.27, p = .002) and perceived self-efficacy (β = -... Due to small cell numbers, single predictors could not be evaluated reliably.... Severity of depression and self-efficacy at baseline were predictors of symptom improvement at level three (Empowerment) of the MEHIRA project. Comorbidity and trauma indicators did not predict outcom...

The ABBA project (Assess Better Before Access): A retrospective cohort study of neonatal intravascular device outcomes.

Venous access devices (VADs) play a vital role within the neonatal intensive care unit. However, there are significant risks associated with the use of VADs, with complications such as infection, thro... This is a retrospective, single-center cohort study that was conducted in a large 112-bed neonatal intensive care unit in Qatar. We examined venous access device data from January 2016 to December 201... The authors recorded a total of 23,858 VADs inserted during the study period. Of these, 21,313 (89%) were peripheral intravenous catheters, 689 (3%) were extended dwell-peripheral intravenous catheter... Four subgroups of VADs were identified (peripheral intravenous catheters, extended dwell-peripheral intravenous devices, epicutaneo-caval catheters, and umbilical venous catheters) with outcome-relate...

Chronic metformin intake and gastric cancer: A pooled analysis within the Stomach cancer Pooling (StoP) Project.

The association between chronic use of metformin and risk of gastric cancer (GC) has been investigated with contradicting results. We aimed to study the association between chronic use of metformin an... Data from three studies of the StoP Project with available information on metformin intake were analyzed. Multivariable logistic regression models were used to estimate study-specific odds ratios (ORs... The OR of GC in metformin users versus non-users was 1.01 (95% CI=0.61, 1.67). The association between metformin and GC did not change among different strata of study participants' characteristics or ... The results of our study do not clearly support an association between chronic use of metformin and GC, warranting further research....

Association of dairy consumption patterns with the incidence of type 2 diabetes: Findings from Alberta's Tomorrow Project.

We aimed to extract dairy consumption patterns of men and women from a population-based cohort and then assess the association of each consumption pattern with incident T2D risk.... This prospective study was conducted within the framework of Alberta's Tomorrow Project (ATP), in which 8615 men and 15,016 women provided information on dietary intake by completing a food-frequency ... Adherence to a DCP characterized by higher consumption of whole milk, regular cheese, and non-fat milk was associated with decreased risk of incident T2D only in men. Our results support current evide...